Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
about
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequencesRASSF2 associates with and stabilizes the proapoptotic kinase MST2RASSF tumor suppressor gene family: biological functions and regulationDNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateAblation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in miceGenetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.The Ras effector RASSF2 controls the PAR-4 tumor suppressor.Death pathways triggered by activated Ras in cancer cellsEPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.DNA methylation: its role in cancer development and therapy.Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer.Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironmentRas signaling through RASSF proteins.RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcomaProteomics Analysis Reveals Novel RASSF2 Interaction Partners.Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy.Differential gene hypermethylation in genital lichen sclerosus and cancer: a comparative study.Comparative analysis of interactions of RASSF1-10.Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.Comparative Modeling, Molecular Docking, and Revealing of Potential Binding Pockets of RASSF2; a Candidate Cancer Gene.Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
P2860
Q24301831-099A8089-94FD-45AD-A03C-4E80046D73E2Q24338394-4DFD7F74-F0A0-44E5-B1EF-DA0F4CFEA2B5Q26866080-BAF998CE-195C-4AA4-ADC4-AF16C6D15047Q28386334-D9064288-A3F5-4AFB-ADBA-51A6B8FB3171Q28509403-0244E671-D3E7-4FD5-96F7-87C1655564D2Q33559593-E8731827-7336-4393-AABE-D4861C5AF7ADQ33877015-C842BFD1-39F7-4921-8CB5-A6D840A240C0Q34994888-9AB8F091-7E2C-4455-9EFC-DDECA197594CQ35238478-61501876-6D6C-46FB-A20B-6D913DC673BCQ36383883-11D7A272-862A-41FE-B142-8217E6A816AEQ36414347-A1B4EA69-2E86-453D-9AB7-3A636B79AD75Q36986433-4DF22B6E-3A6F-4BAE-92A5-D3071591B5E0Q37035724-BC24C19C-1C6A-44DA-823A-A19980AFD476Q37387487-41D42C2A-C61F-44AE-87C5-CFA8795B67C7Q37702087-397C211E-782E-4AA0-AAA1-E5C45F2FF2A0Q38862017-93775727-93C3-4C98-B7F8-0515DE6A5BD2Q39120311-69B9BF40-9329-4155-950C-F23F96F0EEDAQ39583823-3D9A30EC-ACE9-4BA8-B476-154C0A875610Q41083940-192663FB-2419-49DF-A23C-2DD95AE9A5ABQ41202043-73651A05-9FBC-4006-B59E-9509D8494960Q41231684-09959AF6-FBB1-47D7-9CD3-1A4865ABB839Q41878340-0A6C329E-5B6C-47B4-8E64-637141DF9D15Q42184843-44743B29-97D9-4B9C-8B0C-D3E1D060891FQ42272615-BE58DC1B-11B5-44BE-84B1-7E2C1E87E7F5Q42684766-4BDD422D-06A9-4E61-8A8E-97F740013419Q45906493-A4E4E4B2-B15F-44C2-A09C-3904ACAD7769Q52888342-0CBED369-DCAA-4BDF-B0D0-164B6A82EFD9Q53315728-2BEB992B-5004-4EFC-854E-8FA31C810375Q54266041-96347D7C-CD40-41E8-82E0-BAA8548DF459
P2860
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@ast
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@en
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@nl
type
label
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@ast
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@en
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@nl
prefLabel
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@ast
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@en
Epigenetic regulation of the r ...... SF2 in breast and lung cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Epigenetic regulation of the r ...... SSF2 in breast and lung cancer
@en
P2093
E R Zabarovsky
L B Hesson
R E Dickinson
W N Cooper
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210805
P407
P577
2007-09-24T00:00:00Z
P5875
P6179
1032156549